Revolution Medicines, Inc. (RVMD)
152.46
-2.43
(-1.57%)
USD |
NASDAQ |
May 27, 15:41
Revolution Medicines Free Cash Flow : -1.072B for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tango Therapeutics, Inc. | -142.55M |
| Erasca, Inc. | -91.36M |
| Kodiak Sciences, Inc. | -148.12M |
| Kymera Therapeutics, Inc. | -244.00M |
| Spyre Therapeutics, Inc. | -185.87M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -354.16M |
| Cash from Investing (Quarterly) | 172.62M |
| Cash from Financing (Quarterly) | 238.74M |
| Free Cash Flow Per Share (Quarterly) | -1.796 |
| Free Cash Flow to Equity (Quarterly) | -365.83M |
| Free Cash Flow to Firm (Quarterly) | -343.51M |
| Free Cash Flow Yield | -3.64% |